Mangoceuticals, Inc. (MGRX) Financials

$2.27

north_east
$0.08 (3.65%)
Day's range
$2.16
Day's range
$2.45

MGRX Income statement / Annual

Last year (2024), Mangoceuticals, Inc.'s total revenue was $615.87 K, a decrease of 15.81% from the previous year. In 2024, Mangoceuticals, Inc.'s net income was -$8.71 M. See Mangoceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Operating Revenue $615.87 K $731.49 K $8.94 K $0.00
Cost of Revenue $235.91 K $299.99 K $4.09 K $0.00
Gross Profit $379.96 K $431.50 K $4.85 K $0.00
Gross Profit Ratio 0.62 0.59 0.54 0
Research and Development Expenses $0.00 $0.00 $0.00 $0.00
General & Administrative Expenses $6.42 M $3.32 M $1.64 M $0.00
Selling & Marketing Expenses $1.48 M $2.10 M $352.86 K $0.00
Selling, General & Administrative Expenses $7.90 M $5.42 M $2.00 M $17.52 K
Other Expenses $453.79 K $4.23 M $0.00 $0.00
Operating Expenses $8.35 M $9.65 M $2.00 M $17.52 K
Cost And Expenses $8.59 M $9.95 M $2.00 M $17.52 K
Interest Income $0.00 $0.00 $0.00 $0.00
Interest Expense $13.70 K $0.00 $6.47 K $181.00
Depreciation & Amortization $721.53 K $24.89 K $3.86 K $0.00
EBITDA -$7.96 M -$8.09 M -$1.99 M -$17.52 K
EBITDA Ratio -12.93 -11.06 -222.36 0
Operating Income Ratio -12.94 -12.6 -222.8 0
Total Other Income/Expenses Net -$735.00 K $6.47 K -$6.47 K -$181.00
Income Before Tax -$8.71 M -$9.21 M -$2.00 M -$17.70 K
Income Before Tax Ratio -14.14 -12.59 -223.52 0
Income Tax Expense $0.00 $0.00 $0.00 $0.00
Net Income -$8.71 M -$9.21 M -$2.00 M -$17.70 K
Net Income Ratio -14.14 -12.59 -223.52 0
EPS -4.3993 -8.58 -1.7309 -0.0177
EPS Diluted -4.3993 -8.58 -1.7309 -0.0177
Weighted Average Shares Out $1.98 M $1.07 M $1.15 M $997.67 K
Weighted Average Shares Out Diluted $1.98 M $1.07 M $1.15 M $997.67 K
Link